Comparison Between the Assessment of Anxious and Depressive Symptomology
NCT ID: NCT04148924
Last Updated: 2021-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2019-11-15
2020-11-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Physical symptoms are easy to assess. But in palliative care it is important to take care of moral suffering.
However, evaluation and management of patient's anxiety and depressive symptoms are difficult for physicians and caregivers.
The investigators would like to specifically compare the patient's evaluation of anxious and depressive symptomatology in palliative care with the evaluation by the physician, the nurse and the caregiver.
Then the investigators will try to collect the caregivers's difficulties in the management of anxious and depressive symptoms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perceptions of Health Professionals Confronted With Palliative Situations
NCT03021967
Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention
NCT04773639
Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative
NCT01593085
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
Identification of Obstacles and Levers to Interdisciplinary Work in Palliative Care Units
NCT06208644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Anyone who is hospitalized in the palliative care service of the Lyon Sud Hospital Center.
Questionnaire
Patients complete a questionnaire for assess their symptoms like anxiety and depression.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
* HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D)
* BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients.
* Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms.
The evaluation will be realized in the first days of hospitalization (72 hours).
Doctors
Doctors taking care of patients in the study will be solicited by the research nurse or a study investigator.
Medical staff questionnaire
Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).
Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
Nurses
Nurses taking care of patients in the study will be solicited by the research nurse or a study investigator.
Medical staff questionnaire
Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).
Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
Caregivers
Caregivers taking care of patients in the study will be solicited by the research nurse or a study investigator.
Medical staff questionnaire
Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).
Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Patients complete a questionnaire for assess their symptoms like anxiety and depression.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
* HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D)
* BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients.
* Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms.
The evaluation will be realized in the first days of hospitalization (72 hours).
Medical staff questionnaire
Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).
Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.
These questionnaires contains:
* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients (18 years and over)
* Advanced cancer stage
* Patients hospitalized less than 72 hours in Lyon Sud palliative care unit
* Sufficient general conditions to complete survey
* Absence of cognitive disorders
* Agreement to participate at the study
Medical Staff:
\- Working full time or part time in the USP or the PMSC of CHLS
Exclusion Criteria
* Minor patients
* Patients hospitalized more than 72 hours in Lyon Sud palliative care unit
* Presence of cognitive disorders
* Alteration of general conditions
* Refusal to participate at the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Audrey FAWOUBO, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Lyon Sud
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL19_0301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.